Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2372312
Max Phase: Preclinical
Molecular Formula: C53H76N14O12S2
Molecular Weight: 1165.41
Molecule Type: Unknown
Associated Items:
ID: ALA2372312
Max Phase: Preclinical
Molecular Formula: C53H76N14O12S2
Molecular Weight: 1165.41
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CCOc1ccc(C[C@@H]2NC(=O)CC3(CCCCC3)SSC[C@@H](C(=O)N3CCC[C@H]3C(=O)N[C@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc3ccccc3)NC2=O)cc1
Standard InChI: InChI=1S/C53H76N14O12S2/c1-2-79-33-17-15-32(16-18-33)26-36-47(74)64-37(25-31-11-5-3-6-12-31)48(75)62-35(19-20-41(54)68)46(73)65-38(27-42(55)69)49(76)66-39(30-80-81-53(28-44(71)61-36)21-7-4-8-22-53)51(78)67-24-10-14-40(67)50(77)63-34(13-9-23-59-52(57)58)45(72)60-29-43(56)70/h3,5-6,11-12,15-18,34-40H,2,4,7-10,13-14,19-30H2,1H3,(H2,54,68)(H2,55,69)(H2,56,70)(H,60,72)(H,61,71)(H,62,75)(H,63,77)(H,64,74)(H,65,73)(H,66,76)(H4,57,58,59)/t34-,35+,36+,37+,38+,39+,40+/m1/s1
Standard InChI Key: ADXNENDCEGZJJX-UESVSLRLSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1165.41 | Molecular Weight (Monoisotopic): 1164.5209 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Manning M, Lammek B, Bankowski K, Seto J, Sawyer WH.. (1985) Synthesis and some pharmacological properties of 18 potent O-alkyltyrosine-substituted antagonists of the vasopressor responses to arginine-vasopressin., 28 (10): [PMID:4045923] [10.1021/jm00148a019] |
Source(1):